Active, not recruitingPhase 2NCT06365216
ALS Phase II Study of NX210c
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Axoltis Pharma
- Intervention
- NX210c(drug)
- Enrollment
- 80 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2026
Study locations (16)
- Centre Hospitalier Regional Et Universitaire De Brest, Brest, France, France
- Centre Hospitalier Universitaire De Caen Normandie, Caen, France, France
- Hôpital La Timone - APHM, Marseille, France, France
- CHRU De Nancy, Nancy, France, France
- Centre Hospitalier Universitaire d'Angers, Angers, France
- Centre Hospitalier Universitaire De Bordeaux, Bordeaux, France
- CHU de Lyon HCL, Bron, France
- Centre Hospitalier Universitaire de Clermont-Ferrand - Hôpital Gabriel Montpied, Clermont-Ferrand, France
- Centre Hospitalier Universitaire de Lille, Lille, France
- Centre Hospitalier Et Universitaire de Limoges, Limoges, France
- Centre Hospitalier Universitaire de Montpellier, Montpellier, France
- Centre Hospitalier Universitaire de Nantes - Hôpital Nord Laennec, Nantes, France
- Centre Hospitalier Universitaire de Nice, Nice, France
- Hôpital de la Pitié Salpêtrière, Paris, France
- Centre Hospitalier Universitaire de Rennes, Rennes, France
- +1 more locations on ClinicalTrials.gov
Collaborators
ACT4ALS network
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06365216 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGPHASE3NCT07322003Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSPrilenia